PT Royal Prima Tbk (PRIM.JK)
Jakarta · IDR · Healthcare · Medical Care Facilities
IDR 126 (+2.46%) as of
Key statistics
- Market cap
- 425.67B
- EPS (TTM)
- -5.64
- Dividend yield
- 0.00%
- 52-week range
- 64.00 – 134.00
- Beta
- 0.34
- Revenue (TTM)
- 320.78B
- Profit margin
- -5.96%
- Volume
- 1.03M
About PT Royal Prima Tbk
PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical oncology, plastic surgery, pediatric surgery, neurosurgery, digestive surgery, dermatologist and venereologist, psychiatric, dental polyclinic, oral surgery, vascular surgery, kidney and hypertension, endocrine metabolic diabetes. The company was founded in 2013 and is based in Jakarta, Indonesia.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Jakarta, Indonesia
- Employees
- 797
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.